Loading…
Loading…
Danaher Corp
NYSE · Stock Profile · Market Cap $135.27B
Current Price
$191.50
-1.90%GoodMoat Value
$162.73
15.0% overvaluedProfit margin stands at 14.7%.
Forward estimates use 29.3% FCF growth (CAGR)
Net Debt: 13.8B
5.7B
FY24
5.8B
FY24
23.9B
FY24
5.7B
FY25
5.9B
FY25
6.1B
FY25
24.6B
FY25
907M
FY24
818M
FY24
3.9B
FY24
954M
FY25
555M
FY25
908M
FY25
3.6B
FY25
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com. © 2025 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2025-14761 SOURCE Beckman Coulter Diagnostics
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
District Of Columbia, USA
Price sits at 26% of its 52-week range.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
0.64%
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com. © 2025 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2025-14761 SOURCE Beckman Coulter Diagnostics
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
District Of Columbia, USA